Finally, LGALS9 expression was 1.7-fold higher in NSCLC cisplatin-refractory clones as analyzed by microarray and similarly 1.4-fold higher than untreated cells by q-RT-PCR in replicate 3 (Fig. 3b). The gene discussed is LGALS9; the disease is non-small cell lung carcinoma.